abstract |
The invention relates to the use of compounds of the general formula (I)whereinR' represents a hydrogen atom or a C<sub>1-10</sub> alkyl, C<sub>3-7</sub> cycloalkyl, C<sub>3-7</sub> cycloalkyl-(C<sub>1-4</sub>) alkyl, C<sub>3</sub>-<sub>6</sub> alkenyl, C<sub>3-10</sub> alkynyl, phenyl or phenyl-C<sub>1-3</sub> alkyl group; and one of the groups represented byR<sup>2</sup>, R<sup>3</sup> and R<sup>4</sup> is a hydrogen atom or a C<sub>1-3</sub> alkyl, C<sub>3-7</sub>cycloalkyl, C<sub>2-6</sub> alkenyl or phenyl - C<sub>1-3</sub> alkyl group and each of the other two groups, which may be the same or different, represents a hydrogen atom or a C<sub>1-6</sub> alkyl group; and physiologically acceptable salts and solvates thereof, for the relief of nausea and vomiting and/or the promotion of gastric emptying and for the manufacture of a medicament for this purpose. Promotion of gastric emptying may be for the relief of gastro-intestinal disorders associated with gastric stasis or may be of advantage in radiological examination procedures.The invention also relates to a product containing a therapeutic agent liable to induce nausea and vomiting, e.g. a cytostatic agent such as a cyclophosphamide, an alkylating agent or a platinum complex, and a compound of the general formula (1) as a combined preparation for simultaneous separate or sequential use in therapy. |